Evidence map›Paper›PMID 33289546›Full record

ArticleACS synthetic biology2020

Analysis of Complex DNA Rearrangements during Early Stages of HAC Formation.

Elisa Pesenti, Mikhail Liskovykh, Koei Okazaki, Alessio Mallozzi, Caitlin Reid, Maria Alba Abad, A Arockia Jeyaprakash, Natalay Kouprina, Vladimir Larionov, Hiroshi Masumoto and 1 more

Abstract read
In one paragraph

Article in ACS synthetic biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Micronuclei: origins, assays, mechanisms, diseases and treatments.Signal transduction and targeted therapy · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Elisa PesentiWellcome Trust Centre for Cell Biology, Edinburgh EH9 3BF, United Kingdom.ORCID 0000-0002-1958-5411
Mikhail LiskovykhNational Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States.
Koei OkazakiKazusa DNA Research Institute, Kisarazu 292-0818, Japan.
Alessio MallozziWellcome Trust Centre for Cell Biology, Edinburgh EH9 3BF, United Kingdom.
Caitlin ReidWellcome Trust Centre for Cell Biology, Edinburgh EH9 3BF, United Kingdom.
Maria Alba AbadWellcome Trust Centre for Cell Biology, Edinburgh EH9 3BF, United Kingdom.
A Arockia JeyaprakashWellcome Trust Centre for Cell Biology, Edinburgh EH9 3BF, United Kingdom.
Natalay KouprinaNational Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States.ORCID 0000-0001-8690-5625
Vladimir LarionovNational Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States.
Hiroshi MasumotoKazusa DNA Research Institute, Kisarazu 292-0818, Japan.
William C EarnshawWellcome Trust Centre for Cell Biology, Edinburgh EH9 3BF, United Kingdom.

Funding

Biotechnology and Biological Sciences Research Council BB/M018040/1Wellcome Trust 202811/Z/16/Z
6 · The paper itself

Abstract

Human artificial chromosomes (HACs) are important tools for epigenetic engineering, for measuring chromosome instability (CIN), and for possible gene therapy. However, their use in the latter is potentially limited because the input HAC-seeding DNA can undergo an unpredictable series of rearrangements during HAC formation. As a result, after transfection and HAC formation, each cell clone contains a HAC with a unique structure that cannot be precisely predicted from the structure of the HAC-seeding DNA. Although it has been reported that these rearrangements can happen, the timing and mechanism of their formation has yet to be described. Here we synthesized a HAC-seeding DNA with two distinct structural domains and introduced it into HT1080 cells. We characterized a number of HAC-containing clones and subclones to track DNA rearrangements during HAC establishment. We demonstrated that rearrangements can occur early during HAC formation. Subsequently, the established HAC genomic organization is stably maintained across many cell generations. Thus, early stages in HAC formation appear to at least occasionally involve a process of DNA shredding and shuffling that resembles chromothripsis, an important hallmark of many cancer types. Understanding these events during HAC formation has critical implications for future efforts aimed at synthesizing and exploiting synthetic human chromosomes.

Indexed as

Cell Line, TumorCentromereCentromere Protein BChromosomal InstabilityChromosomes, Artificial, HumanEpigenesis, GeneticGene RearrangementGenetic VectorsHumansCentromere Protein BCENP-Acentromereepigenetic engineeringhuman artificial chromosomekinetochoremitosis

Identifiers

PMID33289546
PMCPMC7754191

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.